Stocks › PRAX
Praxis Precision Medicines, Inc. (PRAX) stock analysis
SKIP 1% confidence · analysed Nov 3, 2026
On Nov 3, 2026, our model rated Praxis Precision Medicines, Inc. (PRAX) SKIP with 1% confidence at a price of $280.51. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 69, showing healthy upward momentum without being stretched.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is only 0.4x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: bullish structure intact, no fresh break.
The most recent swing high is $392.70 and the swing low is $238.77; traders often treat these as resistance and support.
Price is sitting in a bearish order block, a zone where large sellers stepped in before, so upside may stall here.
Fundamentals
The company reports a profit margin of 0.0%.
In its latest quarter it earned $-2.87 per share, which beat the $-3.69 analysts expected.
Wall Street's average rating is 1.5 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $650.00.
The next earnings report is expected around Nov 9, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.01 (SKIP). Technicals: RSI 68.58, MACD bullish, price below SMA50. Fundamentals: margin 0.0%. Financial results: last EPS surprise +22.2%, next earnings 2026-11-09. Smart Money Concepts: bullish structure intact, no fresh break, price retesting a bearish order block, sitting inside an unfilled bullish fair value gap. FinGPT news read: positive. Reference price $280.51; no trade levels (SKIP).
Past ratings for PRAX
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 3, 2026 | SKIP | 1% | $280.51 | — |
"Move since" compares each call's price with the latest analysed price.
Frequently asked questions
Is PRAX a buy right now?
As of Nov 3, 2026, our automated model rates Praxis Precision Medicines, Inc. (PRAX) SKIP with 1% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Praxis Precision Medicines, Inc. report earnings next?
The next earnings report is expected around Nov 9, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.